<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35548333</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1663-9812</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in pharmacology</Title>
          <ISOAbbreviation>Front Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pregnancy and Neonatal Outcomes After Exposure to Alprazolam in Pregnancy.</ArticleTitle>
        <Pagination>
          <StartPage>854562</StartPage>
          <MedlinePgn>854562</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">854562</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2022.854562</ELocationID>
        <Abstract>
          <AbstractText>Alprazolam is a commonly prescribed benzodiazepine for anxiety or panic disorder, even in pregnant women. Information on the safety of alprazolam during pregnancy is insufficient. We aimed to evaluate pregnancy and neonatal outcomes after exposure to alprazolam during pregnancy. A prospective study was conducted on 725 pregnancies from January 2000 to December 2019. Participants were recruited through the Korean Mother-Safe Program, a service providing information on drug-induced teratogenic risk during pregnancy and breastfeeding. Exposed (N = 96) and non-exposed (N = 629) women to alprazolam during pregnancy were selected and followed-up until delivery. Pregnancy outcomes, including spontaneous abortion, still birth, low birth weight (LBW), preterm birth, Apgar score (at 1 and 5 min), and malformations were measured and compared. Multivariable logistic regression was performed to examine the association between alprazolam exposure and outcomes. The mean age was 32.9 (SD 4.0) years in the alprazolam-exposed group and 31.8 (SD 3.8) years in the unexposed group (<i>p</i> = 0.008). The alprazolam exposure group demonstrated a significantly higher likelihood of pregnancy and neonatal outcomes: spontaneous abortion (OR = 2.38; 95% CI 1.20-4.69), LBW (OR = 3.65; 95% CI 1.22-11.00), and Apgar score at 1 min ≤ 7 (OR = 2.19; 95% CI 1.02-4.67). There was no significant difference in congenital abnormalities between the exposure and non-exposure groups. Our findings confirmed that alprazolam exposure during pregnancy was significantly associated with adverse pregnancy and neonatal outcomes, including spontaneous abortion, low birth weight, and Apgar score at 1 min ≤ 7. Alprazolam during pregnancy should be appropriately regulated and monitored.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Lee, Koh, Kim, Chun, Han, Hwang, Choi, Joo and Kwon.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Hyunji</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Korean Mother-Safe Counselling Center, Pregnancy and Breastfeeding Medicines Information Center, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Inje University Ilsan Paik Hospital, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koh</LastName>
            <ForeName>Jae-Whoan</ForeName>
            <Initials>JW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Inje University Ilsan Paik Hospital, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Young-Ah</ForeName>
            <Initials>YA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Inje University Ilsan Paik Hospital, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chun</LastName>
            <ForeName>Kyoung-Chul</ForeName>
            <Initials>KC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Inje University Ilsan Paik Hospital, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Jung Yeol</ForeName>
            <Initials>JY</Initials>
            <AffiliationInfo>
              <Affiliation>Korean Mother-Safe Counselling Center, Pregnancy and Breastfeeding Medicines Information Center, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Inje University Ilsan Paik Hospital, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hwang</LastName>
            <ForeName>Jong Hee</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Inje University Ilsan Paik Hospital, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Choi</LastName>
            <ForeName>June-Seek</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>Korean Mother-Safe Counselling Center, Pregnancy and Breastfeeding Medicines Information Center, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Joo</LastName>
            <ForeName>Sung Hong</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Korean Mother-Safe Counselling Center, Pregnancy and Breastfeeding Medicines Information Center, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, National Medical Center, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kwon</LastName>
            <ForeName>Hye-Young</ForeName>
            <Initials>HY</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Biology and Public Health, Mokwon University, Daejeon, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Pharmacol</MedlineTA>
        <NlmUniqueID>101548923</NlmUniqueID>
        <ISSNLinking>1663-9812</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">alprazolam (Alp)</Keyword>
        <Keyword MajorTopicYN="N">anxiety disorders</Keyword>
        <Keyword MajorTopicYN="N">low birth weight (LBW)</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
        <Keyword MajorTopicYN="N">spontaneous abortion (SA)</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>11</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35548333</ArticleId>
        <ArticleId IdType="pmc">PMC9081603</ArticleId>
        <ArticleId IdType="doi">10.3389/fphar.2022.854562</ArticleId>
        <ArticleId IdType="pii">854562</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Ait-Daoud N., Hamby A. S., Sharma S., Blevins D. (2018). A Review of Alprazolam Use, Misuse, and Withdrawal. J. Addict. Med.
12 (1), 4–10. 10.1097/adm.0000000000000350
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/adm.0000000000000350</ArticleId>
            <ArticleId IdType="pmc">PMC5846112</ArticleId>
            <ArticleId IdType="pubmed">28777203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Armstrong C. (2008). ACOG Guidelines on Psychiatric Medication Use during Pregnancy and Lactation. Am. Fam. Physician
78 (6), 772–778. </Citation>
        </Reference>
        <Reference>
          <Citation>
Bais B., Molenaar N. M., Bijma H. H., Hoogendijk W. J. G., Mulder C. L., Luik A. I., et al.  (2020). Prevalence of Benzodiazepines and Benzodiazepine-Related Drugs Exposure before, during and after Pregnancy: A Systematic Review and Meta-Analysis. J. Affect Disord.
269, 18–27. 10.1016/j.jad.2020.03.014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jad.2020.03.014</ArticleId>
            <ArticleId IdType="pubmed">32217339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ban L., Tata L. J., West J., Fiaschi L., Gibson J. E. (2012). Live and Non-live Pregnancy Outcomes Among Women with Depression and Anxiety: A Population-Based Study. PLoS ONE
7 (8), e43462. 10.1371/journal.pone.0043462
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0043462</ArticleId>
            <ArticleId IdType="pmc">PMC3427383</ArticleId>
            <ArticleId IdType="pubmed">22937052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bellantuono C., Tofani S., Di Sciascio G., Santone G. (2013). Benzodiazepine Exposure in Pregnancy and Risk of Major Malformations: a Critical Overview. Gen. Hosp. Psychiatry
35 (1), 3–8. 10.1016/j.genhosppsych.2012.09.003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.genhosppsych.2012.09.003</ArticleId>
            <ArticleId IdType="pubmed">23044244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Creeley C. E., Denton L. K. (2019). Use of Prescribed Psychotropics during Pregnancy: a Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes. Brain Sci.
9 (9), 235. 10.3390/brainsci9090235
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/brainsci9090235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Czeizel A. E., Bod M., Halász P. (1992). Evaluation of Anticonvulsant Drugs during Pregnancy in a Population-Based Hungarian Study. Eur. J. Epidemiol.
8 (1), 122–127. 10.1007/BF03334986
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF03334986</ArticleId>
            <ArticleId IdType="pubmed">1572421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Enato E., Moretti M., Koren G. (2011). The Fetal Safety of Benzodiazepines: an Updated Meta-Analysis. J. Obstet. Gynaecol. Can.
33 (1), 46–48. 10.1016/S1701-2163(16)34772-7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1701-2163(16)34772-7</ArticleId>
            <ArticleId IdType="pubmed">21272436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Eros E., Czeizel A. E., Rockenbauer M., Sorensen H. T., Olsen J. (2002). A Population-Based Case-Control Teratologic Study of Nitrazepam, Medazepam, Tofisopam, Alprazolum and Clonazepam Treatment during Pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol.
101 (2), 147–154. 10.1016/s0301-2115(01)00545-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0301-2115(01)00545-0</ArticleId>
            <ArticleId IdType="pubmed">11858890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Grigoriadis S., Graves L., Peer M., Mamisashvili L., Ruthirakuhan M., Chan P., et al.  (2020). Pregnancy and Delivery Outcomes Following Benzodiazepine Exposure: A Systematic Review and Meta-Analysis. Can. J. Psychiatry
65 (12), 821–834. 10.1177/0706743720904860
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0706743720904860</ArticleId>
            <ArticleId IdType="pmc">PMC7658418</ArticleId>
            <ArticleId IdType="pubmed">32148076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Grigoriadis S., VonderPorten E. H., Mamisashvili L., Tomlinson G., Dennis C. L., Koren G., et al.  (2013). The Impact of Maternal Depression during Pregnancy on Perinatal Outcomes: a Systematic Review and Meta-Analysis. J. Clin. Psychiatry
74 (4), e321–41. 10.1177/070674372090486010.4088/JCP.12r07968
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/070674372090486010.4088/JCP.12r07968</ArticleId>
            <ArticleId IdType="pubmed">23656857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jaiswal A. K. (2002). Effect of Prenatal Alprazolam Exposure on Anxiety Patterns in Rat Offspring. Indian J. Exp. Biol.
40, 35–39. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12561965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Källén B., Borg N., Reis M. (2013). The Use of central Nervous System Active Drugs during Pregnancy. Pharmaceuticals (Basel)
6 (10), 1221–1286. 10.3390/ph6101221
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ph6101221</ArticleId>
            <ArticleId IdType="pmc">PMC3817603</ArticleId>
            <ArticleId IdType="pubmed">24275849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ks S. (2019). 
A Quarter of Koreans Take Prescription Drugs. Korea JoongAng Daily. Retrieved November 5 from Available at: https://koreajoongangdaily.joins.com/2019/04/11/economy/A-quarter-of-Koreans-take-prescription-drugs/3061749.html
. </Citation>
        </Reference>
        <Reference>
          <Citation>
Larsen E. C., Christiansen O. B., Kolte A. M., Nick Macklon N. (2013). New Insights into Mechanisms behind Miscarriage. BMC Med.
11, 154. 10.1186/1741-7015-11-154
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1741-7015-11-154</ArticleId>
            <ArticleId IdType="pmc">PMC3699442</ArticleId>
            <ArticleId IdType="pubmed">23803387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lee J. Y., Kang W. S., Kim J. W., Kim Y. J. (2015). Prescription Patterns of Benzodiazepine for Outpatients in a Psychiatric Department in Korea. Anxiety and mood
11 (2), 143–148. </Citation>
        </Reference>
        <Reference>
          <Citation>
Lee M. H., Choi J. W., Lee J., Shin A., Oh S. M., Jung S. J., et al.  (2019). Trends in Prescriptions for Sedative-Hypnotics Among Korean Adults: a Nationwide Prescription Database Study for 2011-2015. Soc. Psychiatry Psychiatr. Epidemiol.
54 (4), 477–484. 10.1007/s00127-018-1615-x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00127-018-1615-x</ArticleId>
            <ArticleId IdType="pubmed">30406284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ministry of Drug and Food Safety (2021).List of Drugs Contraindicated for Use in Pregnant Women. Available at: https://www.drugsafe.or.kr/iwt/ds/ko/useinfo/EgovDurInfoSerPn.do
(Accessed November 24, 2021). </Citation>
        </Reference>
        <Reference>
          <Citation>
Moosavi S., Pimentel M., Wong M. S., Rezaie A. (2021). Irritable Bowel Syndrome in Pregnancy. Am. J. Gastroenterol.
116 (3), 480–490. 10.14309/ajg.0000000000001124
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14309/ajg.0000000000001124</ArticleId>
            <ArticleId IdType="pubmed">33481381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ornoy A., Arnon J., Shechtman S., Moerman L., Lukashova I. (1998). Is Benzodiazepine Use during Pregnancy Really Teratogenic?
Reprod. Toxicol.
12 (5), 511–515. 10.1016/s0890-6238(98)00035-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0890-6238(98)00035-5</ArticleId>
            <ArticleId IdType="pubmed">9763242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Palagini L., Gemignani A., Banti S., Manconi M., Mauri M., Riemann D. (2014). Chronic Sleep Loss during Pregnancy as a Determinant of Stress: Impact on Pregnancy Outcome. Sleep Med.
15 (8), 853–859. 10.1016/j.sleep.2014.02.013
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.sleep.2014.02.013</ArticleId>
            <ArticleId IdType="pubmed">24994566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rayburn W. F., Christensen H. D., Gold K. M., Gonzalez C. L. (2002). Neurobehavior Effects in Four Strains of Mice Offspring Exposed Prenatally to Alprazolam. Am. J. Obstet. Gynecol.
187 (4), 968–972. 10.1067/mob.2002.127133
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mob.2002.127133</ArticleId>
            <ArticleId IdType="pubmed">12388988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sheehy O., Zhao J. P., Bérard A. (2019). Association between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion. JAMA psychiatry
76 (9), 948–957. 10.1001/jamapsychiatry.2019.0963
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapsychiatry.2019.0963</ArticleId>
            <ArticleId IdType="pmc">PMC6537838</ArticleId>
            <ArticleId IdType="pubmed">31090881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
St Clair S. M., Schirmer R. G. (1992). First-trimester Exposure to Alprazolam. Obstet. Gynecol.
80 (5), 843–846. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1407925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Takzare N., Bakhtiarian A., Saeedi E., Nekoui V. (2011). The Teratogenic Effects of Alprazolam Intake on Rat Fetus. Tehran Univ. Med. J.
68 (10). </Citation>
        </Reference>
        <Reference>
          <Citation>
Tinker S. C., Reefhuis J., Bitsko R. H., Gilboa S. M., Mitchell A. A., Tran E. L., et al.  (20191997–2011). Use of Benzodiazepine Medications during Pregnancy and Potential Risk for Birth Defects, National Birth Defects Prevention Study, 1997-2011. Birth Defects Res.
111 (10), 613–620. 10.1002/bdr2.1497
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/bdr2.1497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
WHO Expert Consultation (2004). Appropriate Body-Mass index for Asian Populations and its Implications for Policy and Intervention Strategies. Lancet
363 (9403), 157–163. 10.1016/S0140-6736(03)15268-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(03)15268-3</ArticleId>
            <ArticleId IdType="pubmed">14726171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
World Health Organization (2021). WHO Collaborating Centre for Drug Statistics Methodology. Available at: https://www.whocc.no
(Accessed November 24, 2021). </Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
